SCHEMBL2886569

SCHEMBL2886569

O=C(O)CCCC/C=C\C/C=C\C/C=C\CCCCCc1cc2ccc(O)cc2oc1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.45
▸ POLB P06746 1/20 0.43
▸ AKR1B10 O60218 2/20 0.42
▸ AKR1B1 P15121 2/20 0.42
▸ ALDH1A1 P00352 8/20 0.41
▸ F7 P08709 5/20 0.41
▸ F3 P13726 5/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ CYP19A1 P11511 3/20 0.41
▸ PPARG P37231 3/20 0.41
▸ PPARD Q03181 3/20 0.41
▸ PPARA Q07869 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ OXER1 Q8TDS5 2/20 0.41
▸ FFAR1 O14842 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ ALOX15 P16050 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4292453 0.98 POLB (0.43) EPHX2POLBAKR1B10AKR1B1ALDH1A1
SCHEMBL4303187 0.98 POLB (0.43) EPHX2POLBAKR1B10AKR1B1ALDH1A1
SCHEMBL29569054 0.84 MMP2 (0.54) EPHX2AKR1B1MAPTHPGDLMNA
SCHEMBL9436016 0.81 KDM4E (0.54) POLBAKR1B10AKR1B1ALDH1A1KDM4E
SCHEMBL4292444 0.80 MIF (0.44) AKR1B10AKR1B1ALDH1A1KDM4EMAPT
SCHEMBL4251337 0.76 HSD17B3 (0.54) POLBALDH1A1KDM4EPPARGMAPT
Water SCHEMBL27385678 0.75 HSD17B3 (0.52) POLBALDH1A1KDM4EPPARGMAPT
SCHEMBL4527127 0.75 HSD17B3 (0.55) POLBAKR1B10AKR1B1ALDH1A1KDM4E
Arachidonic Acid SCHEMBL28529406 0.75 ALDH1A1 (0.56) EPHX2AKR1B1ALDH1A1F7F3
SCHEMBL27844746 0.73 GAA (0.58) POLBAKR1B10AKR1B1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283373-B2 Inhibitors of cytosolic phospholipase A2 PFIZER INC. (US) 2012-10-09 — — US disclosed
EP-2248801-A1 Inhibitors of cytosolic phospholipase a2 Wyeth LLC (US) 2010-11-10 — — EP disclosed
US-20100029645-A1 Inhibitors of Cytosolic Phospholipase A2 WYETH LLC 2010-02-04 — — US disclosed
US-20100022536-A1 Inhibitors of Cytosolic Phospholipase A2 NOVARTIS AG (CH) 2010-01-28 — — US disclosed
US-20090311723-A1 FLUORESCENCE-BASED ASSAY FOR MONOACYLGLYCEROL LIPASE COMPATIBLE WITH INHIBITOR SCREENING WYETH (US) 2009-12-17 — — US disclosed
US-7557135-B2 Inhibitors of cytosolic phospholipase A2 WYETH (US) 2009-07-07 — — US disclosed
EP-1891006-A2 INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 Wyeth a Corporation of the State of Delaware (US) 2008-02-27 — — EP disclosed
US-20070004719-A1 Inhibitors of cytosolic phospholipase A2 WYETH (US) 2007-01-04 — — US disclosed
WO-2006128142-A2 INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 WYETH (US) 2006-11-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090311723-A1 FLUORESCENCE-BASED ASSAY FOR MONOACYLGLYCEROL LIPASE COMPATIBLE WITH INHIBITOR SCREENING MGLL, LIPC, LIPA EPHX2 37/4885POLB 4665/4885AKR1B10 1017/4885
US-20100022536-A1 Inhibitors of Cytosolic Phospholipase A2 PLA2G4B, PLA2G4A, PLA2G12A EPHX2 174/4885POLB 3375/4885AKR1B10 2869/4885
US-20100029645-A1 Inhibitors of Cytosolic Phospholipase A2 PLA2G4B, PLA2G4A, PLA2G12A EPHX2 174/4885POLB 3375/4885AKR1B10 2869/4885
US-20070004719-A1 Inhibitors of cytosolic phospholipase A2 PLA2G4B, PLA2G4A, PLA2G12A EPHX2 174/4885POLB 3375/4885AKR1B10 2869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback